188 related articles for article (PubMed ID: 33771855)
1. Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Pachynski RK; Kim EH; Miheecheva N; Kotlov N; Ramachandran A; Postovalova E; Galkin I; Svekolkin V; Lyu Y; Zou Q; Cao D; Gaut J; Ippolito JE; Bagaev A; Bruttan M; Gancharova O; Nomie K; Tsiper M; Andriole GL; Ataullakhanov R; Hsieh JJ
Clin Cancer Res; 2021 Jun; 27(12):3478-3490. PubMed ID: 33771855
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena.
Khoo A; Liu LY; Sadun TY; Salmasi A; Pooli A; Felker E; Houlahan KE; Ignatchenko V; Raman SS; Sisk AE; Reiter RE; Boutros PC; Kislinger T
J Hematol Oncol; 2022 May; 15(1):48. PubMed ID: 35505417
[TBL] [Abstract][Full Text] [Related]
3. Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.
Houlahan KE; Salmasi A; Sadun TY; Pooli A; Felker ER; Livingstone J; Huang V; Raman SS; Ahuja P; Sisk AE; Boutros PC; Reiter RE
Eur Urol; 2019 Jul; 76(1):18-23. PubMed ID: 30685078
[TBL] [Abstract][Full Text] [Related]
4. Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.
Salami SS; Kaplan JB; Nallandhighal S; Takhar M; Tosoian JJ; Lee M; Yoon J; Hovelson DH; Plouffe KR; Kaffenberger SD; Schaeffer EM; Karnes RJ; Lotan TL; Morgan TM; George AK; Montgomery JS; Davenport MS; You S; Tomlins SA; Curci NE; Kim HL; Spratt DE; Udager AM; Palapattu GS
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914029
[TBL] [Abstract][Full Text] [Related]
5. Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis.
Norris JM; Simpson BS; Freeman A; Kirkham A; Whitaker HC; Emberton M
FASEB J; 2020 Nov; 34(11):14150-14159. PubMed ID: 32920937
[TBL] [Abstract][Full Text] [Related]
6. Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.
Parry MA; Srivastava S; Ali A; Cannistraci A; Antonello J; Barros-Silva JD; Ubertini V; Ramani V; Lau M; Shanks J; Nonaka D; Oliveira P; Hambrock T; Leong HS; Dhomen N; Miller C; Brady G; Dive C; Clarke NW; Marais R; Baena E
Eur Urol Oncol; 2019 Feb; 2(1):1-11. PubMed ID: 30929837
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
8. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
[TBL] [Abstract][Full Text] [Related]
9. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
10. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
Panebianco V; Barchetti G; Simone G; Del Monte M; Ciardi A; Grompone MD; Campa R; Indino EL; Barchetti F; Sciarra A; Leonardo C; Gallucci M; Catalano C
Eur Urol; 2018 Jul; 74(1):48-54. PubMed ID: 29566957
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
12. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
13. Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer.
Cereser L; Giannarini G; Bonato F; Pizzolitto S; Como G; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
Minerva Urol Nephrol; 2022 Feb; 74(1):29-37. PubMed ID: 33016030
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L
BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
[TBL] [Abstract][Full Text] [Related]
16. The visibility of prostate cancer concerning underlying histopathological variances: A single-center multiparametric magnetic resonance imaging study.
Arslan A; Alis D; Tuna MB; Sağlıcan Y; Kural AR; Karaarslan E
Eur J Radiol; 2021 Aug; 141():109791. PubMed ID: 34062471
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging and follow-up to avoid prostate biopsy in 4259 men.
Venderink W; van Luijtelaar A; van der Leest M; Barentsz JO; Jenniskens SFM; Sedelaar MJP; Hulsbergen-van de Kaa C; Overduin CG; Fütterer JJ
BJU Int; 2019 Nov; 124(5):775-784. PubMed ID: 31237388
[TBL] [Abstract][Full Text] [Related]
20. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
